(Press-News.org) TORONTO, Ontario (13 November, 2012) - A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
At present, mesenchymal cells, known to release a series of factors that stimulate tissue repair, and control inflammation, are most commonly harvested from bone marrow. But the new study, headed by Dr. Armand Keating, now suggests that umbilical cord cells outperform bone marrow cells in improving heart muscle function.
The study, released in Cell Transplantation this month, demonstrates that the cells originating from the tissues surrounding the blood vessels of the human umbilical cord, also known as "Wharton's Jelly," outperformed the current gold standard for stem cell therapies for repairing damage to heart muscles, after an induced heart attack when injected directly into the affected area. Dr. Keating calls the HUCPVC results "statistically and significantly better" than bone marrow cells.
Standard heart function tests measured the effect of the therapy after the cells were injected. The HUCPVC cell therapy was twice as effective at repairing damage to heart tissue than no treatment.
"We are hoping that this translates into fewer people developing complications of heart failure because their muscle function after a heart attack is better," states Keating.
Keating and his team will now complete additional pre-clinical studies, and hope to begin clinical trials of the HUCPVC cells on patients within 12-18 months.
Keating is also interested in conducting further research with the umbilical cord cells to overcome the damaging effects of chemotherapy on heart tissue, an agonizing problem for some patients who may be cured of their cancer only to confront heart failure as a result of treatment.
Apart from heart disease, clinical trials with mesenchymal cells are conducted around the world to investigate the treatment of a variety of diseases, including a serious complication of bone marrow transplantation called graft-versus-host disease, autoimmune disorders, neurological diseases and tissue injury arising from lung and liver disease. Today, more than 250 clinical trials are currently being conducted worldwide using mesenchymal cells.
INFORMATION:
About HUCPVCS
The umbilical cord, normally discarded at the birth of a child, is a rich source of stem cells. As this tissue source is commonly discarded after birth, umbilical cords present none of the ethical, or medical, challenges presented by the use of embryonic cells. Evidence shows that these young cells are more biologically potent than similar types of cells harvested from adult donors.
HUCPVC Stem Cells 'Home Grown'
HUCPVCs also represent an economic advantage to Canada, as the platform technology was developed in Ontario, and is provided to leading researchers free of charge by the company that manufactures the cells, Tissue Regeneration Therapeutics (TRT).
"We have a comprehensive family of international patents to protect this important cell source," says Professor J.E. Davies of the University of Toronto's Institute of Biomaterials and Biomedical Engineering (IBBME) and President of TRT. A pioneer in this relatively new field, Davies created this platform technology by filing his first patent in 2003. The first human clinical mesenchymal cell therapies were performed in 2004.
About Dr. Armand Keating
Dr. Armand Keating is Professor of Medicine, Director, Division of Hematology and Epstein Chair in Cell Therapy and Transplantation at the University of Toronto and also a professor at its Institute of Biomaterials and Biomedical Engineering (IBBME). He is Director of the Cell Therapy Program at Princess Margaret and University Health Network and is the current President of the American Society of Hematology.
About IBBME
The Institute of Biomaterials and Biomedical Engineering (IBBME) is an interdisciplinary unit situated between three Faculties at the University of Toronto: Applied Science and Engineering, Dentistry and Medicine.
The Institute pursues research in four areas: neural, sensory systems and rehabilitation engineering; biomaterials, tissue engineering and regenerative medicine; molecular imaging and biomedical nanotechnology; medical devices and clinical technologies.
Umbilical cord cells outperform bone marrow cells in repairing damaged hearts
2012-11-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Study Tracks Brain Gene Response to Territorial Aggression
2012-11-15
CHAMPAIGN, Ill. — With a mate and a nest to protect, the male threespined stickleback is a fierce fish, chasing and biting other males until they go away.
Now researchers are mapping the genetic underpinnings of the stickleback's aggressive behavior. Armed with tools that allow them to see which genes are activated or deactivated in response to social encounters, a team from the University of Illinois has identified broad patterns of gene activity that correspond to aggression in this fish.
A paper describing their work appears in the Proceedings of the Royal Society: ...
Like a game of poker, school programs' success can hinge on principals going 'all in'
2012-11-15
PITTSBURGH—When principals go "all in" in terms of supporting school programs, teachers stand a better chance of successfully implementing change, according to new research published by the University of Pittsburgh and the University of Virginia (UVA).
The researchers report in Prevention Science that if school principals lack enthusiasm or show little support, they are actually viewed as a hindrance by teachers, posing "major challenges" to the success of school programs like the Responsive Classroom®, an approach boasting social-emotional learning. Additionally, apprehensive ...
Women eager to negotiate salaries, when given the opportunity
2012-11-15
Although some scholars have suggested that the income gap between men and women is due to women's reluctance to negotiate salaries, a new study at the University of Chicago shows that given an invitation, women are just as willing as men to negotiate for more pay.
Men, however, are more likely than women to ask for more money when there is no explicit statement in a job description that wages are negotiable, the study showed.
"We find that simple manipulations of the contract environment can significantly shift the gender composition of the applicant pool," said UChicago ...
Study shows different approach after progression in non-small cell lung cancer patients
2012-11-15
DENVER – Right now, the best known treatment for patients with metastatic non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase gene rearrangements (ALK) or epidermal growth factor receptor mutations (EGFR) is crizotinib or EGFR tyrosine kinase inhibitors (TKIs), such as erlotinib, respectively. However, progression inevitably occurs. When it does, having no clear guidelines and/or indications, most patients are treated with chemotherapy. A new study published in the December 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) ...
Study reveals insights that could aid in therapeutic use of mesenchymal stem cells
2012-11-15
BOSTON – Mesenchymal stem cells (MSCs), are a newly emerging cellular therapy being tested in approximately 250 clinical trials worldwide to help repair damaged tissues, such as injured heart muscle following a heart attack. The problem is that when culture-expanded MSCs are injected into the circulation, they have trouble gaining access to the inflamed tissues—exactly where their help is needed.
Now, research led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Brigham and Women's Hospital (BWH) reveals new insights into how MSCs "traffic" from the ...
Youth with autism gravitate toward STEM majors in college -- if they get there
2012-11-15
It's a popularly held belief that individuals with an autism spectrum disorder (ASD) gravitate toward STEM majors in college (science, technology, engineering mathematics).
A new study, co-authored by Paul Shattuck, PhD, assistant professor at the Brown School at Washington University in St. Louis, confirms that view yet finds that young adults with an ASD also have one of the lowest overall college enrollment rates.
The study, "STEM Participation Among College Students with an Autism Spectrum Disorder," was published online Nov. 1 in the Journal of Autism and Developmental ...
Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
2012-11-15
Putnam Valley, NY. (Nov. 15, 2012) – Researchers in Taiwan have developed a "safe, feasible and robust co-culture system" supplied by human umbilical cord mensenchymal stem cells (HUCMSCs) to feed the sustained culture used for human embryonic stem cell (hESC) expansion prior to cell transplantation. The co-culture, said the researchers, "appears to eliminate the most feared characteristic of transplanted hESCs," which is their propensity to form tumors.
The study, published in the current issue of CELL TRANSPLANTATION, is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/. ...
These bots were made for walking: Cells power biological machines
2012-11-15
CHAMPAIGN, Ill. — They're soft, biocompatible, about 7 millimeters long – and, incredibly, able to walk by themselves. Miniature "bio-bots" developed at the University of Illinois are making tracks in synthetic biology.
Designing non-electronic biological machines has been a riddle that scientists at the interface of biology and engineering have struggled to solve. The walking bio-bots demonstrate the Illinois team's ability to forward-engineer functional machines using only hydrogel, heart cells and a 3-D printer.
With an altered design, the bio-bots could be customized ...
USA's ancient hurricane belt and the US-Canada equator
2012-11-15
The recent storms that have battered settlements on the east coast of America may have been much more frequent in the region 450 million years ago, according to scientists.
New research pinpointing the positions of the Equator and the landmasses of the USA, Canada and Greenland, during the Ordovician Period 450 million years ago, indicates that the equator ran down the western side of North America with a hurricane belt to the east.
The hurricane belt would have affected an area covering modern day New York State, New Jersey and most of the eastern seaboard of the ...
Studies in Cell Transplantation investigate oxygen's impact as a factor in transplantation
2012-11-15
Putnam Valley, NY. (Nov. 15, 2012) – Two studies published in the current issue of Cell Transplantation (21:7), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, investigate the role of oxygen in cell transplantation.
In a study carried out at Baylor University, researchers concerned about the poor efficacy of islet cell transplantation during pancreas preservation and islet isolation have found that low temperatures can prevent hypoxia (low oxygen) that can damage islet cells. In a second study, Brazilian researchers found that neural cells ...